January 15, 2021 - Fierce Healthcare
Accolade plans to pay $460 million to acquire 2nd.MD, a company that helps patients get expert medical opinions via video or phone. The deal will create the most comprehensive, integrated healthcare navigation experience in the industry, Accolade officials said. By adding 2nd.MD's services, Accolade will help employers address the urgent medical needs that face employees in 2021.
January 14, 2021 - Fierce Pharma
Pharma companies worldwide scrambled to respond to the COVID-19 pandemic early last year, but so far only a few have advanced therapies and vaccines through to the market. Regeneron is one, and now the drugmaker's antibody cocktail could bring a multibillion-dollar windfall in 2021.
January 15, 2021 - Fierce Healthcare
President-elect Joe Biden’s new $1.9 trillion COVID-19 relief plan includes money for boosting subsidies to help pay down the costs of Affordable Care Act (ACA) exchange plans, bolstering supplies and for vaccine distribution.
January 13, 2021 - Fierce Biotech
Amgen has penned a deal worth $240 million-plus with biotech Evoq Therapeutics as it looks to the future for autoimmune research. Looking to bolster the success of its own autoimmune offerings in the form of Otezla, Enbrel and its growing biosimilar products, Amgen is seeking the next generation of therapies for this highly lucrative disease area.